Free Trial

10 Best Penny Stocks to Buy Now - 3 of 10

→ A new way to collect income from stocks (From DTI) (Ad)
Slide 3
Back to 2
Continue to 4
 
Back to 2
Continue to 4
 

Spruce Biosciences (NASDAQ:SPRB)

Number of Upgrades from Top-Ranked Analysts
4 (in the last 90 days)
Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
2 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$5.67 (655.6% Upside)

About Spruce Biosciences

Spruce Biosciences logoSpruce Biosciences, Inc, a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/14/2024HC WainwrightReiterated RatingNeutral
3/14/2024JMP SecuritiesLower Price TargetMarket Outperform ➝ Market Outperform$8.00 ➝ $3.00
3/14/2024Leerink PartnrsDowngradeOutperform ➝ Market Perform
3/14/2024GuggenheimDowngradeBuy ➝ Neutral
3/14/2024SVB LeerinkDowngradeOutperform ➝ Market Perform$9.00 ➝ $2.00
3/14/2024Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$9.00 ➝ $2.00
3/14/2024LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral
3/14/2024HC WainwrightReiterated RatingBuy ➝ Neutral
3/5/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$9.00
2/26/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$8.00 ➝ $9.00
Slide 3
Back to 2
Continue to 4
 

Automatic Income (from home) (Ad)

Everyone’s talking about this new income hack that could generate triple digit returns on your money. But here’s the best part…

Watch this short video

More From MarketBeat
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
from Banyan Hill Publishing
12 Stocks Corporate Insiders are Abandoning
from MarketBeat
Shocking $16T Elon Musk Crypto Leak
from Crypto 101 Media
20 Stocks to Sell Now
from MarketBeat
Urgent Nvidia Warning
from Altimetry
20 "Past Their Prime" Stocks to Dump From Your Portfolio
from MarketBeat